WHO secures three licensing deals to boost Covid vaccine and assay product options
The World Health Organization has secured licensing agreements with Medigen Vaccine Biologics, the University of Chile and the Spanish National Research Council (CSIC) to increase the number of Covid-19 vaccine and assay product options for worldwide use. The licensing agreements fall under WHO’s Covid-19 Technology Access Pool (C-TAP).
Medigen is the first private manufacturer, as well as the first vaccine maker, to enter an agreement with C-TAP. The Taiwan-based biotech is licensing its Covid-19 vaccine, MVC COVID-19, and providing staff training to manufacturers. The protein subunit vaccine, which has emergency use authorization in Taiwan, has had three million doses administered in seven countries, according to a WHO press release.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.